Courtagen Life Sciences

Courtagen Life Sciences, established in 1999 and based in Woburn, Massachusetts, is a biotechnology firm specializing in proteomic and genomic products and services for the life sciences sector. The company provides essential tools that assist researchers and clinicians in making informed decisions about drug development and patient care. With the slogan "Empowering life sciences with advanced proteomic and genomic solutions for improved drug development and patient care since 1999," Courtagen Life Sciences has positioned itself as a key player in the Biotechnology, Health Care, and Life Sciences industries. The company recently received a Seed Round investment on 25 August 2022, demonstrating continued interest and potential for growth in the biotechnology sector.